Top 20 of Substance Withdrawal Syndrome

Article title # Publications/# Citations

Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.

2002: RZGoldstein; NDVolkow;

400

Drug addiction, dysregulation of reward, and allostasis.

2001: GFKoob; MLe Moal;

371

Drug abuse: hedonic homeostatic dysregulation.

1997: GFKoob; MLe Moal;

320

Signs and symptoms of tobacco withdrawal.

1986: DHatsukami; JRHughes;

269

Addiction motivation reformulated: an affective processing model of negative reinforcement.

2004: TBBaker; MCFiore; MRMajeskie; DEMcCarthy; MEPiper;

266

Addiction.

2002: KCBerridge; TERobinson;

251

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.

1996: KBefort; ADierich; PDollé; JHanoune; BLKieffer; IKitchen; MLe Meur; RMaldonado; ... HWMatthes; BPRoques; FSimonin; SSlowe; ETzavara; OValverde;

228

Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment.

1978: KOFagerström;

204

Review. The incentive sensitization theory of addiction: some current issues.

2008: KCBerridge; TERobinson;

197

Neuroadaptation. Incubation of cocaine craving after withdrawal.

2001: JWGrimm; BTHope; YShaham; RAWise;

189

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

1999: TBBaker; DMDaughton; KDoan; MCFiore; ARHughes; JAJohnston; DEJorenby; SJLeischow; ... MLMuramoto; MANides; SIRennard; SSSmith;

178

Alcoholism: allostasis and beyond.

2003: GFKoob;

175

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

1999: JFAubert; FBeslot; GABohme; GCossu; WFratta; AImperato; CLedent; MParmentier; ... TPedrazzini; FPetitet; BPRoques; OValverde; GVassart;

169

Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse.

2003: DABaker; PWKalivas; RWLake; KMcFarland; HShen; XCTang; SToda;

167

Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety.

2003: MDavis; DJToufexis; DLWalker;

159

A comparison of sustained-release bupropion and placebo for smoking cessation.

1997: ITCroghan; LCDale; EDGlover; PNGlover; RDHurt; JAJohnston; MAKhayrallah; KPOfford; ... DPSachs; DRSchroeder; CRSullivan; PMSullivan;

158

Chronic stress, drug use, and vulnerability to addiction.

2008: RSinha;

158

Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire.

1989: KOFagerström; NGSchneider;

152

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.

2003: TRial of Inhaled STeroids ANd long-acting beta2 agonists study group; JAnderson; PCalverley; AGulsvik; PJones; CMaden; RPauwels; NPride; JVestbo;

147

The development and initial validation of a questionnaire on smoking urges.

1991: DJDrobes; STTiffany;

133